Granulocyte colony-stimulating factor produces long-term changes in gene and microRNA expression profiles in CD34+ cells from healthy donors

• Published in: Haematologica (Roma) 2014-02, Vol.99 (2), p.243-251
• Main Authors: Báez, Alicia, Martín-Antonio, Beatriz, Piruat, José I, Prats, Concepción, Álvarez Laderas, Isabel, Barbado, M. Victoria, Carmona, Magdalena, Urbano Ispizua, Álvaro, Pérez-Simón, José Antonio
• Format: Article
• Language: English
• Subjects: Adult; Antigens, CD34; Blood cells; Blood Donors; Cèl·lules sanguínies; Factors de creixement; Female; Gene Expression Profiling; Gene Expression Regulation - drug effects; Genome-Wide Association Study; Granulocyte-Macrophage Colony-Stimulating Factor - pharmacology; Growth factors; Hematopoietic Stem Cells - cytology; Hematopoietic Stem Cells - metabolism; Humans; Male; Micro RNAs; MicroRNAs; MicroRNAs - biosynthesis; Time Factors
• ISSN: 0390-6078; 1592-8721
• DOI: 10.3324/haematol.2013.086959

Granulocyte colony-stimulating factor is the most commonly used cytokine for the mobilization of hematopoietic progenitor cells from healthy donors for allogeneic stem cell transplantation. Although the administration of this cytokine is considered safe, knowledge about its long-term effects, especially in hematopoietic progenitor cells, is limited. On this background, the aim of our study was to analyze whether or not granulocyte colony-stimulating factor induces changes in gene and microRNA expression profiles in hematopoietic progenitor cells from healthy donors, and to determine whether or not these changes persist in the long-term. For this purpose, we analyzed the whole genome expression profile and the expression of 384 microRNA in CD34(+) cells isolated from peripheral blood of six healthy donors, before mobilization and at 5, 30 and 365 days after mobilization with granulocyte colony-stimulating factor. Six microRNA were differentially expressed at all time points analyzed after mobilization treatment as compared to the expression in samples obtained before exposure to the drug. In addition, 2424 genes were also differentially expressed for at least 1 year after mobilization. Of interest, 109 of these genes are targets of the differentially expressed microRNA also identified in this study. These data strongly suggest that granulocyte colony-stimulating factor modifies gene and microRNA expression profiles in hematopoietic progenitor cells from healthy donors. Remarkably, some changes are present from early time-points and persist for at least 1 year after exposure to the drug. This effect on hematopoietic progenitor cells has not been previously reported.